Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2021;32(1):66-73
Development of an Educational Video for Self-Assessment Of Patients with RA: Steps, Challenges, and Responses
Authors Information

1. Saint-Joseph University, Beirut, Lebanon
2. Weill Cornell Medicine, Doha, Qatar
3. Cairo University, Cairo, Egypt
4. Al-Bashir Hospital, Amman, Jordan
5. Heartbeat Clinic, Beirut, Lebanon
6. Levant Hospital, Beirut, Lebanon
7. Hamad Medical Corporation, Doha, Qatar
8. King Hussein Medical Center, Amman, Jordan
9. Dr Humeira Badsha Medical Center, Dubai, United Arab Emirates
10. Specialized Medical Center, Riyadh, Saudi Arabia
11. King Faisal Specialist Hospital, Jeddah, Saudi Arabia
12. Mediclinic City Hospital, Dubai, United Arab Emirates
13. American University of Beirut, Beirut, Lebanon
14. Lebanese University, Beirut
15. Holy-Spirit University, Kaslik, Lebanon
16. Monla Hospital, Tripoli, Lebanon
17. Al-Zahraa Hospital, Beirut, Lebanon
18. Assiut University, Egypt and King Hamad University Hospital, Bahrain
19. Z-Clinic, Beirut, Lebanon
20. Jordan Hospital, Amman, Jordan

Nelly Ziade

References
  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016;388:2023-38.
  2. Rudan I, Sidhu S, Papana A, Meng S-J, Xin-Wei Y, Wang W, et al. Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J Glob Health 2015;5:010409.
  3. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:1316–22.
  4. Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search update. Ann Rheum Dis 2016;75:16-22.
  5. Jurgens MS, Welsing PMJ, Jacobs JWG. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol Jul-Aug 2012;30(4 Suppl 73):S56-63.
  6. Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2015;75:3-15.
  7. Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
  8. Lukas C, van der Heijde D, Fatenajad S LR. Repair of erosions occurs almost exclusively in damaged joints without swelling. Ann Rheum Dis 2010;69:851-5.
  9. Smolen JS, Han C, van der Heijde DMFM  et al. Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade. Ann Rheum Dis. 2009;68:823-7.
  10. Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guidelines for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2016;68:1-25.
  11. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, et al. Eular Recommendations for the Management of Rheumatoid Arthritis With Synthetic and Biological Disease-Modifying Antirheumatic Drugs: 2016 Update. Ann Rheum Dis 2016;1-51.
  12. Prevoo MLL, Van’T Hof MA, Kuper HH, Van Leeuwen MA, Van De Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty‐eight‐joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
  13. Anderson JK, Zimmerman L, Caplan L MK. Measures of rheumatoid arthritis disease activity: patient (PtGA) and provider (PrGA) global assessment of disease activity, disease activity score (DAS) and disease activity score with 28-joint counts (DAS28), simplified disease activity index (SDAI), cl. Arthritis Care Res 2011;63:S14-36.
  14. Goekoop-Ruiterman YPM, De Vries-Bouwstra JK, Kerstens PJSM, Nielen MMJ, Vos K, Van Schaardenburg D, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis 2010;69:65-9.
  15. Schipper LG, van Hulst LTC, Grol R, van Riel PLCM, Hulscher MEJL, Fransen J. Meta-analysis of tight control strategies in rheumatoid arthritis: Protocolized treatment has additional value with respect to the clinical outcome. Rheumatology 2010;49:2154-64.
  16. Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis 2015;74:954-62.
  17. McDougall JA, Ferucci ED, Glover J, Fraenkel L. Telerheumatology: A Systematic Review. Arthritis Care Res (Hoboken) 2017;69:1546-57.
  18. Grainger R, Townsley H, White B, Langlotz T, Taylor WJ. Apps for People With Rheumatoid Arthritis to Monitor Their Disease Activity: A Review of Apps for Best Practice and Quality. JMIR MHealth UHealth 2017;5:e7.
  19. Seppen BF, L’ami MJ, Duarte dos Santos Rico S, ter Wee MM, Turkstra F, Roorda LD, et al. A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2020;9:e15105.
  20. Mcbain H, Shipley M, Olaleye A, Moore S, Newman S. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: A randomised controlled trial. Ann Rheum Dis 2016;75:1343-9.
  21. Van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, et al. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open 2016;2:1-9.
  22. Gossec L, Cantagrel A, Soubrier M, Berthelot J, Joubert J, Combe B, et al. Sanoïa®, plateforme e-santé interactive d’ auto-évaluation dans la polyarthrite rhumatoïde. Essai comparatif randomisé de 12 mois sur 320 patients. [Sanoïa® , an interactive self-assessment e-health platform for rheumatoid arthritis. Randomized controlled trial of 320 patients 12 months] Rev Rhum 2019;86:52-8. [Article in French]
  23. Abu Abed M, Himmel W, Vormfelde S, Koschack J. Video-assisted patient education to modify behavior: A systematic review. Patient Educ Couns 2014;97:16-22.
  24. The Ohio State University Medical. Effective Use of Audiovisual Materials [Internet]. 2006. Available from: https://ogg.osu.edu/media/documents/health_lit/effective_av.pdf
  25. Know your DAS - National Rheumatoid Arthritis Society [Internet]. [cited 2018 Nov 17]. Available from: https://www.nras.org.uk/patients
  26. Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: Results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis 2015;74:1725-33.
  27. Fahrenwald NL, Belitz C, Keckler A. Outcome evaluation of “sharing the gift of life”: An organ and tissue donation educational program for American indians. Am J Transplant 2010;10:1453-9.
  28. Rosaasen N, Mainra R, Kukha-Bryson A, Nhin V, Trivedi P, Shoker A, et al. Development of a patient-centered video series to improve education before kidney transplantation. Patient Educ Couns 2018;101:1624-9.
  29. Canadian Institutes of Health Research. Canada’s Strategy for Patient-Oriented Research [Internet]. 2011. p. 1-36. Available from: https://cihr-irsc.gc.ca/e/44000.html
  30. Low JK, Crawford K, Manias E, Williams A. A compilation of consumers’ stories: The development of a video to enhance medication adherence in newly transplanted kidney recipients. J Adv Nurs 2016;72:813-24.
  31. Skelton SL, Waterman AD, Davis LA, Peipert JD, Fish AF. Applying best practices to designing patient education for patients with end-stage renal disease pursuing kidney transplant. Prog Transplant 2015;25:77-84.
  32. Jim HSL, Quinn GP, Gwede CK, Cases MG, Barata A, Cessna J, et al. Patient education in allogeneic hematopoietic cell transplant: What patients wish they had known about quality of life. Bone Marrow Transplant 2014;49:299-303.
  33. Massey EK, Tielen M, Laging M, Timman R, Beck DK, Khemai R, et al. Discrepancies between beliefs and behavior: A prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation 2015;99:375-80.
  34. Gordon EJ, Butt Z, Jensen SE, Lok-Ming Lehr A, Franklin J, Becker Y, et al. Opportunities for shared decision making in kidney transplantation. Am J Transplant 2013;13:1149-58.
  35. Urstad KH, Wahl AK, Andersen MH, Øyen O, Fagermoen MS. Renal recipients’ educational experiences in the early post-operative phase - a qualitative study. Scand J Caring Sci 2012;26:635-42.
  36. McWilliams DF, Kiely PDW, Young A, Joharatnam N, Wilson D, Walsh DA. Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis. BMC Rheumatol BMC Rheumatology 2018;2:8.
  37. Fransen J, Stucki G, van Riel PLCM. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Rheum 2003;49:S214-24.
  38. Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, et al. Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: An exemplar of the GRADE Adolopment. Health Qual Life Outcomes 2017 Sep 21;15(1):183.
  39. El Zorkany B, AlWahshi HA, Hammoudeh M, Al Emadi S, Benitha R, Al Awadhi A, et al. Suboptimal management of rheumatoid arthritis in the Middle East and Africa: Could the EULAR recommendations be the start of a solution? Clin Rheumatol 2013;32:151-9.
  40. Halabi H, Alarfaj A, Alawneh K, Alballa S, Alsaeid K, Badsha H, et al. Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis 2015;18:268-75.
  41. Brown T, Goldman SN, Persell SD, Lee JY, Doan CT, Stephens Q, Baker DW, et al. Development and evaluation of a patient education video promoting pneumococcal vaccination. Patient Educ Couns 2017;100:1024-7.
  42. Montealegre JR, Gossey JT, Anderson ML, Chenier RS, Chauca G, Rustveld LO, et al. Implementing targeted cervical cancer screening videos at the point of care. Patient Educ Couns 2014;97:426-9.
  43. Shaffu S, Edwards J, Neame R, Hassan W. Self-assessment of 28-joint disease activity scores by patients with rheumatoid arthritis on anti-TNF therapy. Rheumatology (Oxford) 2013;52:576-8.
  44. Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, et al. Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. Rheumatology (Oxford) 2019;58:1498-9.
  45. Fransen J, van Riel PLCM. The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 2005;23:S93-9.